Fevogrit, a polyherbal medicine, mitigates endotoxin (lipopolysaccharide)-induced fever in Wistar rats by regulating pro-inflammatory cytokine levels

Abstract

Background: Fever is characterized by an upregulation of the thermoregulatory set-point after the body encounters any pathological challenge. It is accompanied by uncomfortable sickness behaviors and may be harmful in patients with other comorbidities. We have explored the impact of an Ayurvedic medicine, Fevogrit, in an endotoxin (lipopolysaccharide)-induced fever model in Wistar rats.

Methods: Active phytoconstituents of Fevogrit were identified and quantified using ultra-high-performance liquid chromatography (UHPLC) platform. For the in-vivo study, fever was induced in male Wistar rats by the intraperitoneal administration of lipopolysaccharide (LPS), obtained from Escherichia coli. The animals were allocated to normal control, disease control, Paracetamol treated and Fevogrit treated groups. The rectal temperature of animals was recorded at different time points using a digital thermometer. At the 6-h time point, levels of TNF-α, IL-1β and IL-6 cytokines were analyzed in serum. Additionally, the mRNA expression of these cytokines was determined in hypothalamus, 24 h post-LPS administration.

Results: UHPLC analysis of Fevogrit revealed the presence of picroside I, picroside II, vanillic acid, cinnamic acid, magnoflorine and cordifolioside A, as bioactive constituents with known anti-inflammatory properties. Fevogrit treatment efficiently reduces the LPS-induced rise in the rectal temperature of animals. The levels and gene expression of TNF-α, IL-1β and IL-6 in serum and hypothalamus, respectively, was also significantly reduced by Fevogrit treatment.

Conclusion: The findings of the study demonstrated that Fevogrit can suppress LPS-induced fever by inhibiting peripheral or central inflammatory signaling pathways and could well be a viable treatment for infection-induced increase in body temperatures.

Keywords

Ayurveda / fever / Fevogrit / lipopolysaccharide / pro-inflammatory cytokines

References

[1] Hasday JD, Thompson C, Singh IS. Fever, immunity, and molecular adaptations. Compr Physiol. 2014; 4(1): 109-148.

[2] El-Radhi AS, Carroll J, Klein N. Clinical Manual of Fever in Children. Springer; 2009.

[3] Ludwig J, McWhinnie H. Antipyretic drugs in patients with fever and infection: literature review. Br J Nurs. 2019; 28: 610-618.

[4] Wrotek S, Legrand EK, Dzialuk A, Alcock J. Let fever do its job. Evol Med Public Health. 2021; 9(1): 26-35.

[5] Prajitha N, Athira SS, Mohanan PV. Pyrogens, a polypeptide produces fever by metabolic changes in hypothalamus: mechanisms and detections. Immunol Lett. 2018; 204: 38-46.

[6] Chidiac AS, Buckley NA, Noghrehchi F, Cairns R. Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease. Expert Opin Drug Metab Toxicol. 2023; 19(5): 297-317.

[7] Wongrakpanich S, Wongrakpanich A, Melhado K. A comprehensive review of non-steroidal anti- inflammatory drug use in the elderly. Aging Dis. 2018; 9(1): 143-150.

[8] Jaeschke H. Acetaminophen: dose-dependent drug hepatotoxicity and acute liver failure in patients. Dig Dis. 2015; 33(4): 464-471.

[9] Balkrishna A, Joshi M, Tomer M, et al. Identification, validation and standardization of bioactive molecules using UPLC/MS-QToF, UHPLC and HPTLC in Divya-Denguenil-Vati: a Penta-herbal formulation for dengue fever. Chromatographia. 2022; 85(9): 831-850.

[10] Nair A, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016; 7(2): 27.

[11] Jedrzejewski T, Piotrowski J, Kowalczewska M, Wrotek S, Kozak W. Polysaccharide peptide from Coriolus versicolor induces interleukin 6-related extension of endotoxin fever in rats. Int J Hyperth. 2015; 31(6): 626-634.

[12] Ajaz M, Akram M, Asif HM, et al. Phytochemical screening and antipyretic effects of hydroalcoholic extracts of selected medicinal plants of Rawalakot, Azad Jammu and Kashmir in albino rats. Pak J Pharm Sci. 2019; 32(2): 581-592.

[13] Dela Justina V, Gonçalves JS, de Freitas RA, et al. Increased O-linked N-acetylglucosamine modification of NF-ΚB and augmented cytokine production in the placentas from hyperglycemic rats. Inflammation. 2017; 40(5): 1773-1781.

[14] Zhang LQ, Gao SJ, Sun J, et al. DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation. J Neuroinflammation. 2022; 19(1): 1-24.

[15] Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001; 25(4): 402-408.

[16] Roth J, Blatteis CM. Mechanisms of fever production and lysis: lessons from experimental LPS fever. Compr Physiol. 2014; 4(4): 1563-1604.

[17] Antwi AO, Obiri DD, Osafo N, Forkuo AD, Essel LB. International immunopharmacology stigmasterol inhibits lipopolysaccharide-induced innate immune responses in murine models. Int Immunopharmacol. 2017; 53: 105-113.

[18] Khan MB, Rathi B. Tinospora cordifolia-an immunomodulatory drug in ayurveda for prevention and treatment of covid-19. Int J Res Pharm Sci. 2020; 11(Special Issue 1): 1695-1699.

[19] Suman A, Kumar Sharma R, Khan A, Professor A. Evaluation of anti-inflammatory and antipyretic effect of aqueous extract of Tinospora Cordifolia in rats. Int J Res Rev Vol. 2019; 6(8): 340-347.

[20] Jacob J, Babu BM, Mohan MC, Abhimannue AP, Kumar BP. Inhibition of proinflammatory pathways by bioactive fraction of Tinospora cordifolia. Inflammopharmacology. 2018; 26(2): 531-538.

[21] Parihar S. Swertia chirata-a wonderful herb. Indian J Pharm Biol Res. 2021; 9(4): 10-15.

[22] Sharma N, Kumar A. Antipyretic activity of Swertia chirayita in methanolic extract. Int J Pharm Sci Rev Res. 2017; 42(1): 50-53.

[23] Lad H, Bhatnagar D. Amelioration of oxidative and inflammatory changes by Swertia chirayita leaves in experimental arthritis. Inflammopharmacology. 2016; 24(6): 363-375.

[24] Bose M, Chakraborty M, Bhattacharya S, et al. Suppression of NF-κB p65 nuclear translocation and tumor necrosis factor-α by Pongamia pinnata seed extract in adjuvant-induced arthritis. J Immunotoxicol. 2014; 11(3): 222-230.

[25] Rekha MJ, Bettadaiah BK, Muthukumar SP, Govindaraju K. Synthesis, characterization and anti-inflammatory properties of karanjin (Pongamia pinnata seed) and its derivatives. Bioorg Chem. 2021; 106: 104471.

[26] Bawankule D, Kumar A, Agarwal K, et al. Pharmacological and phytochemical evaluation of Ocimum sanctum root extracts for its antiinflammatory, analgesic and antipyretic activities. Pharmacogn Mag. 2015; 11(42): 217.

[27] Kumari I, Kaurav H, Chaudhary G. Ethnobotanical significance of Picrorhiza kurroa (Kutki), a threatened species. Int J Res Rev. 2021; 8(4): 363-375.

[28] Almeleebia TM, Alsayari A. Pharmacological and clinical efficacy of Picrorhiza kurroa and its secondary metabolites: a comprehensive review. Molecules. 2022; 27: 8316.

[29] Kumar R, Gupta YK, Singh S, Raj A. Anti-inflammatory effect of Picrorhiza kurroa in experimental models of inflammation. Planta Med. 2016; 82(16): 1403-1409.

[30] Kumar R, Nair V, Gupta YK, Singh S. Anti-inflammatory and anti-arthritic activity of aqueous extract of Rosa centifolia in experimental rat models. Int J Rheum Dis. 2017; 20(9): 1072-1078.

[31] Shen B, Zhao C, Chen C, et al. Picroside II protects rat lung and A549 cell against LPS-induced inflammation by the NF-κB pathway. Inflammation. 2017; 40: 752-761.

[32] Ma S, Wang X, Lai F, Lou C. The beneficial pharmacological effects and potential mechanisms of picroside II: evidence of its benefits from in vitro and in vivo. Biomed Pharmacother. 2020; 130: 110421.

[33] Guo S, Jiang K, Wu H, et al. Magnoflorine ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation. Front Pharmacol. 2018; 9: 1-11.

[34] Ullah R, Ikram M, Park TJ, et al. Vanillic acid, a bioactive phenolic compound, counteracts LPS-induced neurotoxicity by regulating c-Jun N-terminal kinase in mouse brain. Int J Mol Sci. 2021; 22: 361.

[35] Ruwizhi N, Aderibigbe BA. Cinnamic acid derivatives and their biological efficacy. Int J Mol Sci. 2020; 21(16): 1-36.

RIGHTS & PERMISSIONS

2024 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.